Jason Co., Ltd. (TYO:3080)

Theseus Pharmaceuticals Revenue

Jason had revenue of 6.87B JPY in the quarter ending May 31, 2025, a decrease of -4.76%. This brings the company's revenue in the last twelve months to 27.95B, down -2.46% year-over-year. In the fiscal year ending February 28, 2025, Jason had annual revenue of 28.30B, down -1.54%.

• Revenue (ttm): 27.95B
• Revenue Growth: -2.46%
• P/S Ratio: 0.31
• Revenue / Employee: 169.42M
• Employees: 165
• Market Cap: 8.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	28.30B	-443.00M	-1.54%
Feb 29, 2024	28.74B	1.51B	5.56%
Feb 28, 2023	27.23B	951.00M	3.62%
Feb 28, 2022	26.28B	-274.00M	-1.03%
Feb 28, 2021	26.55B	2.18B	8.95%